Pharmacokinetics of Single‐Dose Dolutegravir in HIV‐Seronegative Subjects With Moderate Hepatic Impairment Compared to Healthy Matched Controls

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|2|4|342-348

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.2, Iss.4, 2013-10, pp. : 342-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Single‐dose pharmacokinetics of bupropion hydrobromide and metabolites in healthy adolescent and adult subjects

By  

Clinical Pharmacology In Drug Development, Vol. 2160-763X, Iss. 5, 2015-09 ,pp. : 346-353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single‐dose pharmacokinetics of bupropion hydrobromide and metabolites in healthy adolescent and adult subjects

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 346-353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Age, Sex, and Obesity on the Single‐Dose Pharmacokinetics of Omarigliptin in Healthy Subjects

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 5, 2016-09 ,pp. : 374-382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Cinacalcet in Hepatic Impairment: Phase I, Open-Label, Parallel-Group, Single-Dose, Single-Centre Study

By Padhi Desmond  

Clinical Drug Investigation, Vol. 28, Iss. 10, 2008-01 ,pp. : 635-643

Adis International

Access to resources Recommend Favorite

Effects of Nilotinib on Single-Dose Warfarin Pharmacokinetics and Pharmacodynamics: A Randomized, Single-Blind, Two-Period Crossover Study in Healthy Subjects

By Yin Ophelia Q.P.  

Clinical Drug Investigation, Vol. 31, Iss. 3, 2011-03 ,pp. : 169-179

Adis International

Access to resources Recommend Favorite